The collaboration with Merck is overwhelmingly positive. The...

The collaboration with Merck is overwhelmingly positive. The initial bladder cancer results from VLA must be promising enough for Merck to want to collaborate. I know the SP is just sitting there like a snail but VLA is doing all the right things and getting potential pharma partners interested. McColl must have a good basis for saying Cavatak will likely follow T-vec and be the second oncoloytic virus approved.

I expect a further announcement re the bladder cancer results shortly.